<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0001397'>Hepatic steatosis</z:hpo> is common in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>It is causally linked to the features of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Experimental data have indicated that increased liver fat may impair hepatic perfusion and metabolism </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the current study was to assess hepatic parenchymal perfusion, together with <z:chebi fb="105" ids="17234">glucose</z:chebi> and fatty acid metabolism, in relation to hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: Fifty-nine men with well controlled type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 18 age-matched healthy normoglycemic men were studied using <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography to assess hepatic tissue perfusion, insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi>, and fasting fatty acid metabolism, respectively, in relation to hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content, quantified by proton magnetic resonance spectroscopy </plain></SENT>
<SENT sid="5" pm="."><plain>Patients were divided into two groups with hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content below (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-low) or above (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-high) the median of 8.6% </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-high patients had the highest BMI and A1C and lowest whole-body insulin sensitivity (ANOVA, <z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with control subjects and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-low patients, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-high patients had the lowest hepatic parenchymal perfusion (P = 0.004) and insulin-stimulated hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (P = 0.013) </plain></SENT>
<SENT sid="8" pm="."><plain>The observed decrease in hepatic fatty acid influx rate constant, however, only reached borderline significance (P = 0.088) </plain></SENT>
<SENT sid="9" pm="."><plain>In type 2 diabetic patients, hepatic parenchymal perfusion (r = -0.360, P = 0.007) and hepatic fatty acid influx rate constant (r = -0.407, P = 0.007) correlated inversely with hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content </plain></SENT>
<SENT sid="10" pm="."><plain>In a pooled analysis, hepatic fat correlated with hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (r = -0.329, P = 0.004) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In conclusion, type 2 diabetic patients with increased hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> content showed decreased hepatic parenchymal perfusion and hepatic insulin mediated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake, suggesting a potential modulating effect of hepatic fat on hepatic <z:mp ids='MP_0001532'>physiology</z:mp> </plain></SENT>
</text></document>